FSEV 2026

Auditorium - Level -1SESSION 4: EVs & Central and Peripheral Nervous System

Joint session with the German Society for EVs (GSEV)

Chairs: Dr Julia GROSS (HMU Potsdam, Germany) & Dr Martial CAILLAUD (INSERM, Nantes)

• Pr Franz RICKLEFS (UKE, Germany)
  Liquid biopsy for CNS Tumors using Tumor-Secreted Extracellular Vesicles

Short talks

• S4.1 - Gaelle GUIRAUDIE-CAPRAZ (INP, Marseille)
  Toward a cell-free therapy with olfactory ecto-mesenchymal stem cells-derived extracellular vesicles to repair peripheral nerves

• S4.2 - Antonin MARQUANT (Karolinska Institute, Sweden)
  A Gene Therapy Platform for in situ secretion of Extracellular Vesicles-loaded Glucocerebrosidase in Brain

• S4.3 - Jean-Christophe DELPECH (NutriNeuro, INRAE, Bordeaux)
  Gestational omega-3 deficiency is associated with changes in content and function of brain-derived extracellular vesicles

Patio 44-45 - Ground floor & Level -1Coffee break

Patio 44-45 - Ground floor & Level -1POSTER SESSION 1 - odd-numbered

Auditorium - Level -1SESSION 5: EVs & Cell Biology (II)

Joint session with the French Club EXOENDO

Chairs: Dr Sophie ROME (INRAE, Lyon) & Dr Vincent HYENNE (INSERM, Strasbourg)

• Dr Sophie ROME (INRAE, Lyon)
  When lipids leave the cell via extracellular vesicles: How immune cells protect and challenge tissue homeostasis

Short talks

• S5.1 - Lisa MENNENS (Hasselt University, Belgium)
  Extracellular Vesicle Secretion Dynamics and Proteomic Signature in Human Multipotent Adipose-Derived Stem Cells from Donors with/without Obesity

• S5.2 - Mireia GOMEZ DURO (Institut Curie, Paris)
  CD133 Controls Protrusion Architecture and Defines a Non-Canonical Extracellular Vesicle Biogenesis Pathway in Basal-Like Triple-Negative Breast Cancer

SPONSOR SESSION 2

Chair: Mehdi KABANI (CNRS, Le Kremlin-Bicêtre)

• Agilent
  Detection and Counting of Small Particles with the New NovoCyte Flow Cytometer
  Emeric DERUY (Business Development Manager, Flow Cytometry, Agilent)

• Cytek biosciences
  Enhanced Small Particle™ Detection Option from Cytek®
  Haley PUGSLEY (Cytek Biosciences)

• Univercells Technologies
  Impact of bioprocess design on extracellular vesicle yield and quality
  Thomas ROBERT(Univercells Technologies)

Patio 44-45 - Ground floor & Level -1Lunch

Patio 44-45 - Ground floor & Level -1POSTER SESSION 2 - even-numbered

Auditorium - Level -1‘Meet the experts’ - Event organized by the YN-FSEV

Auditorium - Level -1FSEV General Assembly

FSEV 2026 PhD award flash talk

SESSION 6: EVs & Technology (II)

Joint session with the French Society of Nanomedicine (SFNano)

Chairs: Dr Emilie VÉLOT (CNRS, Université de Lorraine, Vandœuvre-lès-Nancy) &
Dr Marie MAUMUS (IRMB, Montpellier)

• Dr Andrey KLYMCHENKO (CNRS, Université de Strasbourg)
  Fluorescent probes for imaging and sensing cell membranes and extracellular vesicles

Short talks

• S6.1 - Olivier DE JONG (Utrecht University, Netherlands)
  Extracellular vesicle-mediated CRISPR-Cas9 delivery using aptamer-based loading and release strategies

• S6.2 - Mehdi DOLLEANS (Institut Galien Paris-Saclay, Orsay)
  CZE-TDA as an Analytical Platform for Extracellular Vesicle Characterization and Monitoring of EV-Lipid Nanoparticle Hybrid Formation

• S6.3 - Maryam HANINE (Institut de Chimie Physique Paris-Saclay, Orsay)
  IR nanospectroscopy as a label-free morpho-chemical characterization method for Extracellular Vesicles

Patio 44-45 - Ground floor & Level -1Coffee break

Patio 44-45 - Ground floor & Level -1POSTER SESSION 2 - even-numbered

Auditorium - Level -1SESSION 7: EVs & Clinical applications

Joint session with the Italian Society for EVs (EVIta)

Chairs: Pr Paolo CIANA (University of Milan, Italy) &
Dr Annalisa RADEGHIERI (University of Brescia, Italy)

• Pr Paolo CIANA (University of Milan, Italy)
  EV-based labeling of solid tumors for precision surgery: initial results from the ONCOGREEN Phase I/II clinical trial

Short talks

• S7.1 - Iris MARANGON (Hôpital Fondation Adolphe de Rothschild, Paris)
  Extracellular vesicles derived from mesenchymal stromal cells overexpressing COL7A1: a novel topical therapy for corneal dystrophic epidermolysis bullosa

• S7.2 - Analucia CONCA (C2VN, Marseille)
  Rheopheresis increases thrombolytic potential through the generation of fibrinolytic neutrophil-derived extracellular vesicles

• S7.3 - Romaric LACROIX (C2VN, Marseille)
  The coagulolytic balance of extracellular vesicles in sepsis: predicting mortality and stratifying coagulopathy

Day 2 closing - Information for day 3

Péniche - Paris 12^eCongress dinner